We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$92.6M
AUM Growth
+$5.75M
Cap. Flow
+$2.75M
Cap. Flow %
2.97%
Top 10 Hldgs %
32.24%
Holding
102
New
26
Increased
26
Reduced
27
Closed
15

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.58M
2
VTRS icon
Viatris
VTRS
+$3.19M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.28M
4
ELV icon
Elevance Health
ELV
+$1.89M
5
MSFT icon
Microsoft
MSFT
+$1.76M

Top Sells

Rank Stock Value
1
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
+$4.96M
2
NOW icon
ServiceNow
NOW
+$1.78M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.34M
4
CI icon
Cigna
CI
+$1.28M
5
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 56.86%
2 Technology 15.15%
3 Communication Services 6.25%
4 Financials 3.98%
5 Consumer Discretionary 3.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BABA icon
26
Alibaba
BABA
$308B
$1.33M 1.43%
7,222
-2,106
-23% -$397K
XNTK icon
27
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
$1.32M 1.43%
+15,100
New +$1.37M
THC icon
28
Tenet Healthcare
THC
$21.1B
$1.21M 1.31%
+49,814
New +$992K
A icon
29
Agilent Technologies
A
$41.2B
$1.2M 1.3%
+18,003
New +$1.26M
RVTY icon
30
Revvity
RVTY
$12.8B
$1.2M 1.29%
15,810
+1,803
+13% +$139K
HCA icon
31
HCA Healthcare
HCA
$89.5B
$1.19M 1.28%
12,214
-3,321
-21% -$322K
ESPR
32
DELISTED
Esperion Therapeutics
ESPR
$1.17M 1.26%
16,110
+3,970
+33% +$292K
MDCO
33
DELISTED
Medicines Co
MDCO
$1.15M 1.24%
34,980
+1,319
+4% +$41.2K
AMZN icon
34
Amazon
AMZN
$2.96T
$1.15M 1.24%
15,840
-140
-0.9% -$10K
XYZ
35
Block Inc
XYZ
$47.5B
$1.13M 1.22%
22,972
+4,050
+21% +$186K
HOLX
36
DELISTED
Hologic
HOLX
$1.1M 1.19%
29,392
+2,814
+11% +$114K
ACOR
37
DELISTED
Acorda Therapeutics
ACOR
$1.1M 1.18%
386
-59
-13% -$177K
INTU icon
38
Intuit
INTU
$89B
$1.09M 1.18%
+6,277
New +$1.06M
BOX icon
39
Box
BOX
$4.6B
$1.08M 1.17%
52,746
-21,373
-29% -$460K
RHT
40
DELISTED
Red Hat Inc
RHT
$1.01M 1.09%
+6,774
New +$939K
PEN icon
41
Penumbra
PEN
$12.8B
$997K 1.08%
8,618
-2,353
-21% -$243K
BPMC
42
DELISTED
Blueprint Medicines
BPMC
$958K 1.04%
10,446
+426
+4% +$36.7K
ATVI
43
DELISTED
Activision Blizzard
ATVI
$951K 1.03%
14,092
-3,889
-22% -$275K
VTRS icon
44
CALL
Viatris
VTRS
$18.9B
$856K 0.92%
+20,800
New +$887K
PCRX icon
45
Pacira BioSciences
PCRX
$997M
$741K 0.8%
+23,798
New +$847K
TFX icon
46
Teleflex
TFX
$5.98B
$703K 0.76%
+2,759
New +$725K
DVA icon
47
DaVita
DVA
$11.7B
$700K 0.76%
10,619
-11,402
-52% -$837K
COUP
48
DELISTED
Coupa Software Incorporated
COUP
$646K 0.7%
14,166
+5,254
+59% +$216K
AGIO icon
49
Agios Pharmaceuticals
AGIO
$1.93B
$640K 0.69%
+7,821
New +$605K
NFLX icon
50
Netflix
NFLX
$309B
$621K 0.67%
21,010
-17,360
-45% -$473K
1
2
3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Partner Investment Management held 102 positions worth $92.6M, up 6.6% from $86.8M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management's Q1 2018 filing shows 26 new, 26 increased, 27 reduced and 15 closed positions. Its largest new stake was Bristol-Myers Squibb: 55,719 shares worth $3.52M. The largest sale was Sienna Biopharmaceuticals, Inc., an estimated $4.96M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.

  • Partner Investment Management's largest Q1 2018 buy was Bristol-Myers Squibb: 55,719 shares worth $3.52M.
  • Partner Investment Management added most to Elevance Health in Q1 2018, an estimated $1.89M increase.
  • Partner Investment Management's biggest Q1 2018 reduction was Sienna Biopharmaceuticals, Inc., cutting an estimated $4.96M.
  • Partner Investment Management fully exited ServiceNow in Q1 2018, selling an estimated $1.78M.
  • Partner Investment Management's ten largest holdings make up 32% of its $92.6M portfolio in Q1 2018.
  • Partner Investment Management opened 26 new positions and closed 15 in Q1 2018.
  • Partner Investment Management's portfolio value rose 6.6% quarter-over-quarter to $92.6M.

Based on Partner Investment Management's 13F filing for Q1 2018, filed 15 May 2018.